Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Biochemical Pharmacology|March 23, 1999
Defects of tyrosine289phenylalanine mutation on binding and functional properties of the human tachykinin NK2 receptor stably expressed in chinese hamster ovary cellsA R Renzetti, R M Catalioto, C Carloni, et al.The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptorS Meini, L Quartara, A Rizzi, et al.The Journal of Steroid Biochemistry and Molecular Biology|May 28, 2003
Pharmacological profile of MEN 11066, a novel potent and selective aromatase inhibitorM Muratori, A Lippi, R Mancina, et al.The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
Nepadutant pharmacokinetics and dose-effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent modelsA Lecci, F Carini, M Tramontana, et al.Journal of Medicinal Chemistry|March 19, 1993
1,2-Cyclomethylenecarboxylic monoamide hydroxamic derivatives. A novel class of non-amino acid angiotensin converting enzyme inhibitorsL Turbanti, G Cerbai, C Di Bugno, et al.The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptorA R Renzetti, R M Catalioto, M Criscuoli, et al.European Journal of Neurology|January 28, 2009
Age of puberty and the risk of multiple sclerosis: a population based studyS V Ramagopalan, W Valdar, M Criscuoli, et al.British Journal of Pharmacology|March 4, 1998
MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonistR M Catalioto, M Criscuoli, P Cucchi, et al.Canadian Journal of Physiology and Pharmacology|June 1, 1997
Tachykinin receptors and intestinal motilityC A Maggi, R M Catalioto, M Criscuoli, et al.Pageof 7